EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of a hemolytic assay of the alternative complement pathway in human serum


American Journal of Clinical Pathology 74(2): 167-173
Evaluation of a hemolytic assay of the alternative complement pathway in human serum
Alternative complement [C] pathway activity of human serum was titrated by use of unsensitized rabbit erythrocytes (RE). Under the conditions of the assay, the von Krogh equation was used to relate the proportion of RE lysed to the level of alternative pathway activity. The use of a 50% hemolytic endpoint provided maximum sensitivity in the assay. The 50% hemolytic endpoint could be calculated from a single measurement in the region of 20-80% lysis of RE. Factor B was required for lysis of RE in the test; neither C2 nor C8 was limiting under the conditions of the assay. Alternative pathway activities of 3 sera with abnormal Ig[immunoglobulin]G levels were in the normal range; normal serum absorbed with RE at 0.degree. C before testing had diminished lytic activity with the test. Lysis of RE in acute-phase sera of 16 patients who had bacteremic pneumococcal pneumonia was significantly below normal (P < 0.01). Results with RE lysis in these patients correlated well with levels of Factor B that were measured immunochemically and with consumption of whole complement by zymosan.


Accession: 005395140

PMID: 7405895

DOI: 10.1093/ajcp/74.2.167



Related references

A simple alternative pathway for hemolytic assay of human complement c 3 using methylamine treated plasma. Journal of Immunological Methods 60(1): 89-100, 1983

A simple alternative pathway for hemolytic assay of human complement component C3 using methylamine-treated plasma. Journal of Immunological Methods 60(1-2): 89-100, 1983

A non-hemolytic assay for the activity of the alternative pathway of bovine complement. Veterinary Immunology and Immunopathology 38(1-2): 155-167, 1993

A non-hemolytic assay for the activation of the alternative pathway of bovine complement. Veterinary Immunology & Immunopathology. 38(1-2): 155-167, 1993

Clinical adaptation of a hemolytic alternative complement pathway assay. Clinical Research 25(3): 357A, 1977

Non hemolytic assay for the activation of the bovine alternative pathway of complement. Complement & Inflammation 8(3-4): 203, 1991

A hemolytic plate method for alternative-pathway complement activity assay. American Journal of Clinical Pathology 69(2): 156-160, 1978

Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum. Journal of Clinical Investigation 73(1): 160-170, 1984

Characterization of alternative complement hemolytic pathway activity in Holstein bull serum. Acta Zoologica Sinica 52(4): 698-705, 2006

Alternative pathway hemolytic complement titer ach50 of porgy pagrus major serum. Nippon Suisan Gakkaishi 53(10): 1887-1892, 1987